Lana Golubovic-Macukanovic
Nis, SE, Serbia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Generic Imatinib in Chronic Myeloid Leukemia Treatment: Long-Term Follow-up.
Journal: Clinical lymphoma, myeloma & leukemia
Published: February 21, 2019
The significance of angiogenesis for predicting optimal therapeutic response in chronic myeloid leukaemia patients.
Journal: Polish journal of pathology : official journal of the Polish Society of Pathologists
Published: January 25, 2018
Analyses of Treatment Outcome According to Age in Patients With Chronic Myeloid Leukemia Receiving Front-line Imatinib Therapy.
Journal: Clinical lymphoma, myeloma & leukemia
Published: April 17, 2017
The importance of Myd88 L265P mutation, clinical and immunohistochemical prognostic factors for the survival of patients with diffuse large B-cell non-Hodgkin lymphoma treated by immunochemotherapy in southeast Serbia.
Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology
Published: November 13, 2016
Serbian lymphoma study group: demografic characteristics of 257 patients with follicular lymphoma.
Journal: Vojnosanitetski pregled
Published: August 01, 2015
Improved prediction of clinical outcome in chronic myeloid leukemia.
Journal: International journal of hematology
Published: July 23, 2014
Evaluation of coagulation factors in fresh frozen plasma treated with riboflavin and ultraviolet light
Journal: Vojnosanitetski pregled
Published: March 09, 2012
Factors associated with achievement and durability of cytogenetic response in patients with chronic myeloid leukemia treated with imatinib
Journal: Vojnosanitetski pregled
Published: December 24, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026